An Act relative to prescription medication re-authorization

HD 1369 prohibits licensed health insurers (subject to specific Massachusetts insurance laws) from requiring annual re-authorizations for prescription drugs treating chronic conditions. It directly affects patients with conditions like diabetes, heart disease, Alzheimer's, cancer, stroke, or respiratory disease, as well as their insurers. The bill's key provision bans insurers from demanding yearly approval for these specific medications once a physician, physician's assistant, or nurse practitioner has prescribed them. This changes the current process by eliminating an administrative hurdle for ongoing treatment of chronic illnesses.